These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22086127)

  • 41. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
    Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
    Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
    Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
    Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of erythropoietin on angiogenesis after myocardial infarction in porcine.
    Kawachi K; Iso Y; Sato T; Wakabayashi K; Kobayashi Y; Takeyama Y; Suzuki H
    Heart Vessels; 2012 Jan; 27(1):79-88. PubMed ID: 22038108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.
    Ceelen W; Boterberg T; Smeets P; Van Damme N; Demetter P; Zwaenepoel O; Cesteleyn L; Houtmeyers P; Peeters M; Pattyn P
    Br J Cancer; 2007 Mar; 96(5):692-700. PubMed ID: 17299396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
    Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
    Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.
    Kumar A; Sunita P; Jha S; Pattanayak SP
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):939-50. PubMed ID: 27297262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
    Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
    BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
    Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
    Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Pratheeshkumar P; Son YO; Budhraja A; Wang X; Ding S; Wang L; Hitron A; Lee JC; Kim D; Divya SP; Chen G; Zhang Z; Luo J; Shi X
    PLoS One; 2012; 7(12):e52279. PubMed ID: 23300633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.
    Mu X; Shi W; Sun L; Li H; Jiang Z; Zhang L
    Molecules; 2012 Jun; 17(6):6854-68. PubMed ID: 22669041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
    Li X; Gonias SL; Campana WM
    Glia; 2005 Sep; 51(4):254-65. PubMed ID: 15812815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
    Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
    Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
    Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
    J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice.
    Huang C; Wang Y; Huang JH; Liu W
    BMC Pharmacol Toxicol; 2017 Jul; 18(1):55. PubMed ID: 28683823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.
    Yu W; Chai H; Li Y; Zhao H; Xie X; Zheng H; Wang C; Wang X; Yang G; Cai X; Falck JR; Yang J
    Toxicol Appl Pharmacol; 2012 Oct; 264(1):73-83. PubMed ID: 22841774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
    Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
    Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.